Lilly Asia, Qiming, HongShan et al Double Down on Cell Therapy Tech
22 Oct 2024
US$ 19.00
Lilly Asia Ventures, Qiming Venture Partners, HongShan and FreesFund, all existing investors of XellSmart ......
Tag
Biotech
Related Publications
Circulate Capital has agreed to invest US$9.5 m for a significant minority stake in Jayachandran Global Refineries ......
Australia’s IFM Investors Pty Ltd (IFM), one of the largest infrastructure-focused asset managers, announced the ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.